Behavioral Tracking of Zebrafish Motion for Treatment Efficacy

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a limited understanding of the mechanisms underlying the therapeutic effects of psilocybin, a psychedelic compound, in treating mood-related disorders, and current methods for assessing treatment efficacy in psychiatric disorders are not sufficiently reliable or comprehensive, particularly in subcortical structures like the brainstem and cerebellum.

Innovation Solution

A method and system using larval zebrafish as a model animal, combined with wide-field behavioral tracking and machine learning, to analyze treatment-related imagery and determine the efficacy of substances like psilocybin by extracting motion features and calculating behavioral indicators, which includes training machine learning models to classify movement patterns and assess treatment efficacy.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If traditional methods are used to assess treatment efficacy in psychiatric disorders, then the assessment process is simple, but the reliability and comprehensiveness of the assessment is insufficient

Engineering Contradiction:
Improveassessment reliabilityVSAvoidsystem complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent replaces traditional mechanical/visual assessment methods with an automated computer vision system that captures video of animal behavior and uses machine learning algorithms to objectively quantify movement patterns. This substitution transforms subjective assessment into objective, data-driven measurement, significantly improving reliability while the automation reduces the perceived complexity through software-based processing.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces an intermediary computational layer between the treatment intervention and the efficacy assessment. This intermediary system processes raw video data through dimensionality reduction algorithms and machine learning models to extract meaningful behavioral indicators, serving as a bridge that translates complex biological responses into quantifiable metrics for reliable assessment.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Loss of information

If comprehensive behavioral analysis is performed to understand subcortical mechanisms, then the understanding depth increases, but the time and resources required increase

Engineering Contradiction:
Improveinformation completenessVSAvoidanalysis time
Core Design Contradiction:
Loss of informationVSLoss of time

Solution Approach 1:

The patent segments the complex behavioral analysis task into distinct components: video capture, motion feature extraction, dimensionality reduction, and classification. By dividing the analysis pipeline into modular stages, the system can process comprehensive behavioral data systematically, maintaining information completeness while reducing overall analysis time through parallel processing and optimized computation at each stage.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent performs preliminary dimensionality reduction on motion features before final classification and interpretation. By pre-processing the data to extract essential patterns and reduce redundancy early in the pipeline, the system preserves critical information while minimizing the computational burden for subsequent analysis steps, thereby reducing total analysis time without sacrificing comprehensiveness.

Inventive Principle:
Principle #10Preliminary action

3Measurement precision

If machine learning models are trained to classify movement patterns, then the precision of behavioral classification improves, but the computational complexity increases

Engineering Contradiction:
Improveclassification precisionVSAvoidcomputational complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent applies dimensionality reduction algorithms to motion features before training the machine learning classification model. This preliminary processing step transforms high-dimensional raw data into a lower-dimensional feature space that retains the most informative patterns, enabling the classifier to achieve high precision with reduced computational complexity and faster training times.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent transforms the parameter space by converting raw motion features into dimensionally reduced representations that capture essential behavioral patterns. This parameter transformation maintains the discriminative power needed for precise classification while reducing the number of parameters the machine learning model must process, thereby improving precision without proportionally increasing computational complexity.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS20260038304A1Method and system for determining efficacy of treatment by a predetermined substance
Publication Date: 2026.02.05 YEDA RES & DEV CO LTD
  • US20260038304A1 patent drawing
  • US20260038304A1 patent drawing
  • US20260038304A1 patent drawing

AI summary

A system and method of determining efficacy of treatment by at least one processor may include receiving, from at least one camera, images depicting motion of an animal that may be treated with a predetermined substance of interest. Said processor may extract from the images, a plurality of motion features representing motion of at least one specific body part of the animal, and apply a dimensionality reduction algorithm on the plurality of motion features, to obtain a latent vector representing the plurality of motion features in a latent space. The latent vector may include a plurality of latent features. Said processor may subsequently calculate a value of a behavioral indicator, representing a behavior of the animal, based on the latent features of the latent vector, and determine efficacy of the treatment based on the behavioral indicator value.